GLP-1s Arent a One-Size-Fits-All Solution Experts stress that the results should not be interpreted as proof that everyone with obesity and an autoimmune disease should take a GLP-1 medication
GLP-1 induces cell proliferation, PDX-1 expression and increpases endocrine cell mass in the pncreas of old glucose-intolerant rats
Kaku K, Yamada Y, Watada H, Abido A, Nishida T, Zacho J, Kiyosue A
Exendin-4 shares only 53% amino acid sequence identity with human GLP-1, and that difference turned out to be everything
However, enzyme supplements may cause their own gastrointestinal side effects that can overlap with GLP-1-related symptoms, and some formulations containing bromelain or papain may interact with anticoagulants
Compared with LIXI, LIR is more effective in improving blood glucose and reducing weight, and both treatments are well tolerated (75, 77, 78)